Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 173 results for "Suboxone Tablets"

Opiate declines in Md. prisons after cut from Medicaid list

| ANNAPOLIS, Md. — Since Suboxone film strips were removed from the Medicaid Preferred Drug List in July, the amount of the drug recovered in Maryland correctional facilities as contraband has decreased by 41 percent, according to Maryland's ... Washington Post, 1 month ago

4 images for Suboxone Tablets

Monthly Prescribing Reference, 2 months ago
Proactive Investors.co.uk, 2 months ago
CNN, 3 months ago
CNN Money, 5 months ago

Suboxone Reckitt Benckiser sued by 35 states for 'profiteering' from opioid treatment

British multinational is accused of shamelessly preying on patients in need of help by keeping Suboxone, a drug used to treat addiction, at an inflated price Dozens of US states have accused a British multinational company of shamelessly preying on ...
 The Guardian1 month ago Reckitt Benckiser sued by 35 US states for profiteering from opioid treatment  ExecReview.com1 month ago

U.S. FDA Approves Orexo's Low Dose ZUBSOLV® Buprenorphine and Naloxone Sublingual Tablets (CIII)

MORRISTOWN, N.J. , Oct. 6, 2016 /PRNewswire/ -- Orexo US announced today that the U.S. Food and Drug Administration (FDA) has approved ZUBSOLV ® (buprenorphine/naloxone CIII sublingual tablet) 0.7mg/0.18mg for the treatment of patients with opioid ...
 Barchart2 months ago Orexo AB (ORXOY: OTCQX International) | U.S. FDA Approves Orexo's Low Dose ZUBSOLV® Buprenorphine and Naloxone Sublingual Tablets (CIII)  OTC Markets2 months ago
[x]  

Maryland Prisons Report 41% Drop In Contraband Suboxone Film Following Medicaid PDL Change

News Report | December 4, 2016 Maryland prisons report that contraband seizures of Suboxone film, a thin dissolvable formulation of oral buprenorphine and naloxone used for opioid dependence treatment, dropped by 41% between July and October 2016 ...
 Open Minds.com1 day ago

Maker of Opioid Addiction Treatment Drug Suboxone Accused of Conspiring to Keep Monopoly Profits

, Attorney General Chris Carr and 41 other attorneys general filed an amended antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block ...
 Attorney General: Georgia1 week ago AG Balderas: Maker of Opioid Addiction Treatment Drug Suboxone Accused of Conspiring to Keep Monopoly Profits  Pharmacy Choice2 weeks ago

New Hampshire Joins 41 States in Filing Lawsuit Against Makers of Opioid Treatment Drug Suboxone

CONCORD, N.H., Nov. 17 New Hampshire Attorney General Joseph A. Foster issued the following news release: Attorney General Joseph A. Foster and 41 other attorneys general today filed an amended antitrust lawsuit against the makers of Suboxone, a ...
 Pharmacy Choice2 weeks ago AG Files Suit Against Opioid Treatment Drug Maker  Healthcare Journal of Baton Rouge1 month ago Drug company challenged  Pharmacy Choice2 months ago Coffman Sues Drug Companies for Taking Advantage of Opioid Crisis  Attorney General: Colorado1 month ago

OREXO : Mundipharma and Orexo announce EU regulatory submission for Zubsolv®

· Mundipharma and Orexo make first EU regulatory submission for Zubsolv® (buprenorphine and naloxone) sublingual tablet · Zubsolv was approved in the US in 2013 for the maintenance treatment of opioid dependence, as part of a complete treatment ...
 4 Traders2 months ago Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv  PipelineReview2 months ago EU regulatory submission for Zubsolv® from Mundipharma and Orexo AB  HospitalHealthcare.com1 month ago Orexo announce EU regulatory submission  Nordic Life Science2 months ago
[x]  

10/7/16 - Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg

By a News Reporter-Staff News Editor at Drug Week Lannett Company, Inc. (NYSE: LCI) announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Buprenorphine and Naloxone ...
 Pharmacy Choice1 month ago

Drug Delivery Systems Technology & Market Analysis, Market Segmentation Application Research

(Before It's News) BUCCAL Drug Delivery Systems Market analysis is provided for global market including development trends by regions, competitive analysis of the BUCCAL Drug Delivery Systems market. BUCCAL Drug Delivery Systems Industryreport ...
 Before It's News5 days ago

MonoSol Rx Submits New Drug Application for Tadalafil PharmFilm®

Warren N.J., Nov. 28, 2016 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm ® drug delivery technology to improve patient outcomes and to address unmet needs, today announced that it has filed a New Drug ...
 4 Traders1 week ago MonoSolRx LLC Submits New Drug Application For Tadalafil PharmFilm  BioSpace6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less